Cart 0

Season of Hope

2 slide carousel of gabe.jpg
 
 

Together, our impact brings hope.

Hope for a better tomorrow.

Hope to cancer patients and families.

Hope for better treatments and cures for rare cancers.

As she continued to train with a rare cancer diagnosis, Gabe Grunewald famously coined the phrase, “Running on Hope.” Hope sustained her. It empowered her. It inspired her to create the Brave Like Gabe Foundation. To date, we’ve been able to grant $2.25 Million to fund rare cancer research with the goal of finding more treatments and cures. Join us in #RunningOnHope and making a difference in rare cancer research.

“I find the courage to keep running and racing through hope. Hope for a future treatment that might work for me and for others in similar situations. That hope comes from research. You could say I run on hope.”

GABE GRUNEWALD

gabegrunwald-jennackerman-05-1558275993.jpg
 

Research Impact

We are proud to share that since the founding of the Brave Like Gabe Foundation in 2018, we have granted $2,252,467 to multiple institutions: Memorial Sloan Kettering Cancer Center, Fred Hutchinson Cancer Research Center, Dana-Farber Cancer Institute, Adenoid Cystic Carcinoma Research Foundation and University of Minnesota - Masonic Cancer Center.

 
 

Pediatric Osteosarcoma ImMUNOTHERAPY

At the University of Minnesota Masonic Cancer Center, Dr. Branden Moriarity and Abigail Anderson Fellowship Recipient, Bibek Kar, are developing cellular immunotherapies that will be translatable to the clinic for osteosarcoma and other pediatric cancers. The Brave Like Gabe Foundation grant has helped secure more than $1.1M in additional funding.

Transformative Rare Cancer Initiative

Dr. Taran Gujral, at the Fred Hutchinson Cancer Center has created a drug-matching platform that uses artificial intelligence to address the challenges of rare cancer research. The Transformative Rare Cancer Initiative (TRACER) is advancing research on Rhabdomyosarcoma and LAMN, paving the way for innovative treatment approaches and ultimately enhancing patient care through detailed genetic analysis and molecular profiling of these uncommon tumors.

Disparities in Pancreatic Cancer

Dr. Balogun and Dr. Chakravarty at Memorial Sloan Kettering Cancer Center are researching disparities in pancreatic cancer. Pancreatic cancer is agressive and rare, yet the third-highest cause of cancer mortality. There are higher incidence and mortality rates in underserved and diverse communities. They seek to gain insight into the pathogenesis of pancreatic cancer by broadening more accurate patient tumor samples.

2 slide carousel of gabe.jpg

“But I really think, no matter what phase you are in on your cancer journey, you have to hold onto hope. Hope that health is in your future, maybe, or even just hope that there is meaningful life in the time you have left.”

GABE GRUNEWALD

Season of Hope.png

Brave Stories of Hope

Since 2018, we’ve received countless submissions of stories that share of bravery and hope in spite of something challenging. We invite you to read these stories and be reminded of the bravery of those pushing through adversity.

 

Stay Connected!

 
2 slide carousel of gabe.jpg